Lineage Cell Therapeutics (LCTX) Total Debt (2014 - 2021)

Lineage Cell Therapeutics (LCTX) posted quarterly Total Debt of $523000.0 for Q1 2021, little changed quarter-over-quarter from $523000.0 in Q4 2020.

Lineage Cell Therapeutics (LCTX) Total Debt (2014 - 2021) Analysis & Trends

Lineage Cell Therapeutics' Total Debt history runs 6 years deep, the most recent figure standing at $523000.0 for Q1 2021.

  • In Q1 2021, Total Debt changed N/A year-over-year to $523000.0; the TTM figure through Mar 2021 stood at $523000.0 (changed N/A YoY), while the FY2020 annual figure was $523000.0, changed N/A from the prior year.
  • Total Debt for Q1 2021 stood at $523000.0, roughly flat from $523000.0 in the prior quarter.
  • The five-year high for Total Debt was $523000.0 in Q2 2020, with the low at $18000.0 in Q4 2017.
  • The 3-year median for Total Debt is $309000.0 (2017), against an average of $293000.0.
  • Peak annual rise in Total Debt reached 45.09% in 2017, while the deepest fall reached 85.0% in 2017.
  • Lineage Cell Therapeutics' Total Debt stood at $18000.0 in 2017, then jumped by 2805.56% to $523000.0 in 2020, then changed by 0.0% to $523000.0 in 2021.
  • Business Quant data shows LCTX's Total Debt at $523000.0 in Q1 2021, $523000.0 in Q4 2020, and $523000.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.07 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 9.34 Bn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 546.77 Mn
10 Lineage Cell Therapeutics 270.61 Mn 212.77 Mn 1.07 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2021 523,000.00
Dec 31, 2020 523,000.00
Sep 30, 2020 523,000.00
Jun 30, 2020 523,000.00
Dec 31, 2017 18,000.00
Sep 30, 2017 44,000.00
Jun 30, 2017 95,000.00
Mar 31, 2017 95,000.00
Dec 31, 2016 120,000.00
Sep 30, 2016 173,000.00
Jun 30, 2016 173,000.00
Mar 31, 2016 220,000.00
Dec 31, 2015 246,000.00
Sep 30, 2015 268,000.00
Jun 30, 2015 3,000.00
Mar 31, 2015 17,307.00
Dec 31, 2014 31,000.00
Sep 30, 2014 44,963.00
Jun 30, 2014 57,500.00